TO STUDY THE EFFECT OF MEDOPACHAK GHANVATI IN RAS RAKTAGAT SNEHA VRIDDHI WITH SPECIAL REFERENCE TO HYPERLIPIDEMIA
Phase 2
- Conditions
- Health Condition 1: E785- Hyperlipidemia, unspecified
- Registration Number
- CTRI/2021/08/035363
- Lead Sponsor
- Dr Seema Vitthal Rathod
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with high blood lipid profile.Lipid profile showing any one or more of the following criteria was considered diagnostic of hyperlipidemia .
Exclusion Criteria
1.Pregnant women & lactating mother.
2.Chronic illness and infection like TB, CA and HIV infection.
3.Patient is suffering with psychological disorders like anxiety, depression.
4.Patient with Respiratory Diseases Complications, Coronary Heart Disease,Infective Hepatitis,Alcoholic Hepatitis or Renal Disease etc.
5.Drug induced Hyperlipidemia.
6.Patients having a history of untreated thyroid disorder.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Changes in Lipid Profile by Medopachak Ghanvati towards the Normal levels at the end treatment. <br/ ><br>Lipid profile showing increased level anyone or more of following criteria will considered diagnostic of hyperlipidemia: <br/ ><br>Serum Total Cholesterol <br/ ><br>Serum Triglycerides <br/ ><br>Serum HDL Cholesterol <br/ ><br>Serum LDL Cholesterol <br/ ><br>Serum VLDL Cholesterol <br/ ><br> <br/ ><br>Timepoint: 60days <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1. To reduce risk factors for many diseases including cardiovascular disease and metabolic syndrome <br/ ><br>2.TO assess the efficacy of medopachk Ghanvati in HyperlipidemiaTimepoint: 60days